HAEMONETICS CORP (HAE) › Operating IncomeHAEMONETICS CORP (HAE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $85.57M2010: $83.28M2011: $110.55M2012: $88.76M2013: $56.44M2014: $46.43M2015: $40.54M2016: -$43.94M2017: -$19.38M2018: $56.16M2019: $83.55M2020: $103.35M2021: $89.75M2022: $80.75M2023: $156.03M2024: $164.88M2025: $221.82M2026: $156.73M$156.73M2009Operating Income (USD)2026Fiscal YearOperating IncomeChange YoY2026$156.73M-29.3%2025$221.82M+34.5%2024$164.88M+5.7%2023$156.03M+93.2%2022$80.75M-10.0%2021$89.75M-13.2%2020$103.35M+23.7%2019$83.55M+48.8%2018$56.16M+389.8%2017-$19.38M+55.9%2016-$43.94M-208.4%2015$40.54M-12.7%2014$46.43M-17.7%2013$56.44M-36.4%2012$88.76M-19.7%2011$110.55M+32.7%2010$83.28M-2.7%2009$85.57M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share